Sodium restriction decreases AP-1 activation after nephron reduction in the rat: Role in the progression of renal lesions

Experimental Nephrology

Volumn 8, Issue 2, 2000, Pages 104-114

  Terzi, Fabiola ^a   Burtin, Martine ^a   Hekmati, Mehrak ^a   Jouanneau, Chantal ^b   Beaufils, Hélène ^b   Friedlander, Gérard ^a  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

AP 1; Cell proliferation; Proto oncogenes; Remnant kidney; Renal lesions; Sodium restriction

Indexed keywords

PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DNA BINDING; HYPERPLASIA; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NEPHRECTOMY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SODIUM RESTRICTION;

EID: 0034026541     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020656     Document Type: Article

References (40)

1. Hostetter TH: Progression of renal disease and renal hypertrophy. Annu Rev Physiol 1995;57: 263-278.
2. Olivetti G, Anversa P, Rigamonti W, Vitali ML, Loud AV: Morphometry of the renal corpuscle during normal post-natal growth and compensatory hypertrophy. A light microscope study. J Cell Biol 1977;75:573-580.
3. Miskell CA, Simpson DP: Hyperplasia precedes increased glomerular filtration rate in rat remnant kidney. Kidney Int 1990;37:748-766.
4. Kleim V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved in thepathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996;49:666-678.
5. Terzi F, Beaufils H, Laouari D, Burtin M, Kleinknecht C: Renal effect of antihypertensive drugs depends on sodium diet in the excision remnant kidney model. Kidney Int 1992; 42:354-363.
6. McCreight CE, Sulkin NM: Compensatory renal hyperplasia following experimental surgical deletions of the kidney complement. Am J Anat 1962;110:199-202.
7. Goss RJ: Kinetics of compensatory growth. Q Rev Biol 1965;40:123-146.
8. Karin M, Liu ZG, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 1997;9:240-246.
9. McMahon SB, Monroe JG: Role of primary response genes in generating cellular responses to growth factors. FASEB J 1992;6:2707-2715.
10. Terzi F, Burtin M, Friedlander G: Early molecular mechanisms in the progression of renal failure: Role of growth factors and proto-oncogenes. Kidney Int Suppl 1998;53:68-73.
11. Ryseck RP, Bravo R: c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: Effect of FOS proteins. Oncogene 1991;6:533-542.
12. Curran T, Franza BJ: Fos and Jun: The AP-1 connection. Cell 1988;55:395-397.
13. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072: 129-157.
14. Cowley BJ, Chadwick LJ, Grantham JJ, Calvet JP: Sequential protooncogene expression in regenerating kidney following acute renal injury. J Biol Chem 1989;264:8389-8393.
15. Norman JT, Bohman RE, Fischmann G, Bowen JW, McDonough A, Slamon D, Fine LG: Patterns of mRNA expression during early cell growth differ in kidney epithelial cells destined to undergo compensatory hypertrophy versus regenerative hyperplasia. Proc Natl Acad Sci USA 1988;85:6768-6772.
16. Ouellette AJ, Mall RA, Sukhatme VP, Bonventre JV: Expression of two 'immediate early' genes. Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest 1990;85:766-771.
17. Safirstein R, Price PM, Saggi SJ, Harris RC: Changes in gene expression after temporary renal ischemia. Kidney Int 1990;37:1515-1521.
18. Rosenberg ME, Paller MS: Differential gene expression in the recovery from ischemic renal injury. Kidney Int 1991;39:1156-1161.
19. Terzi F, Ticozzi C, Burtin M, Motel V, Beaufils H, Laouari D, Assael BM, Kleinknecht C: Subtotal but not unilateral nephrectomy induces hyperplasia and proto-oncogene expression. Am J Physiol 1995;268:F793-F801.
20. Meyer TW, Rennke HG: Progressive glomerular injury after limited renal infarction in the rat. Am J Physiol 1988;254:F856-F862.
21. Purkerson ML, Hoffsten PE, Klahr S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 1976;9: 407-417.
22. Benstein JA, Feiner HD, Parker M, Dworkin LD: Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol 1990; 27:F1675-F1681.
23. Daniels BS, Hostetter TH: Advene effects of growth in the glomerular microcirculation. Am J Physiol 1990;258:F1409-F1416.
24. Dechaux M, Limal JM, Broyer M, Sachs C: Micro determination of plasma renin activity in normal infants and children of capillary and venous blood. Clin Chim Acta 1979;99:93-95.
25. Cereghini S, Raymondjean M, Carranca AG, Herbomel P, Yaniv M: Factors involved in control of tissue-specific expression of albumin gene. Cell 1987;50:627-638.
26. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
27. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen PD, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297-309.
28. Keith DS, Torres VE, Johnson CM, Holley KE: Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats. Am J Kidney Dis 1994;24:491-498.
29. Tingle LE, Cameron IL: Cell proliferation response in several tissues following combined unilateral nephrectomy and high salt diet in mice. Tex Rep Biol Med 1973;31:537-549.
30. Loffing J, Le HM, Kaissling B: Modulation of salt transport rate affects DNA synthesis in vivo in rat renal tubules. Kidney Int 1995;47: 1615-1623.
31. Hayslett JP: Functional adaptation to reduction in renal mass. Physiol Rev 1979;59:137-164.
32. Kobayashi S, Clemmons DR, Nogami H, Roy AK, Venkatachalam MA: Tubular hypertrophy due to work load induced by furosemide is associated with increases of IGF-1 and IGFBP-1. Kidney Int 1995;47:818-828.
33. Johnson RS, Spiegelman BM, Papaioannou V: Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992;71:577-586.
34. Johnson RS, van Lingen B, Papaioannou VE, Spiegelman BM: A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev 1993;7: 1309-1317.
35. Hilberg F, Aguzzi A, Howells N, Wagner EF: c-jun is essential for normal mouse development and hepatogenesis. Nature 1993;365: 179-181.
36. Kataoka S, Alam R, Dash PK, Yatsu FM: Inhibition of PDGF-mediated proliferation of vascular smooth muscle cells by calcium antagonists. Stroke 1997;28:364-369.
37. Sakurai H, Shigemori N, Hisada Y, Ishizuka T, Kawashima K, Sugita T: Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: Molecular mechanisms of anti-nephritic action. Biochim Biophys Acta 1997;1362:252-262.
38. Seto M, Kim S, Yoshifusa H, Nakamura Y, Masuda T, Hamaguchi A, Yamanaka S, Iwao H: Effects of prednisolone on glomerular signal transduction cascades in experimental glomerulonephritis. J Am Soc Nephrol 1998;9:1367-1376.
39. Vrtovsnik F, Couette S, Prie D, Lallemand D, Friedlander G: Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway. Kidney Int 1997;52:1016-1027.
40. Megyesi J, Di MJ, Udvarhelyi N, Price PM, Safirstein R: DNA synthesis is dissociated from the immediate-early gene response in the post-ischemic kidney. Kidney Int 1995;48: 1451-1458.